Dr. Petrin's Presentations at International Pharmaceutical Meetings

• Preparation of the European Registration Dossier. Arlington, VA, USA, 1994
• Meeting Regulatory Requirements for a Drug Approval in South Korea. IBC Conference, London, UK, 1997
• Conducting Clinical Trials in the Emerging Markets: Problems and Pitfalls: Experiences in Asia-Pacific Region. DIA Annual Meeting, Boston, MA, USA, 1998
• Conducting Clinical Trials in the Emerging Markets: Problems and Pitfalls. Session Chairman. DIA Annual Meeting, Boston, MA, USA, 1998
Meeting Regulatory Requirements for a Drug Approval in Indonesia. IBC Conference, London, UK, November 1998
• Short term issues for the international pharmaceutical industry: Identifying and overcoming the presubmission and local requirements for regulatory submissions in the emerging markets: South America Region. At: The Registration of Pharmaceuticals in Emerging Markets. CMR International, Surrey, UK, November 1998
• Strategies for the long-term development of registration in the emerging markets: Session Rapporteur. At: The Registration of Pharmaceuticals in Emerging Markets. CMR International, Surrey, UK, November 1998
• Global Drug Development. Annual AAPS Meeting, San Francisco, CA, November 1998
• Regulatory Strategies for NCE Products in the Emerging Markets. Global Regulatory Strategy Conference, IBC, London, February 1999
• Regulatory Strategies for Early Introduction of New Pharmaceutical Products in the Emerging Markets. Session Chairman. DIA Annual Meeting, Baltimore, MD, June 1999
• Invited Expert to the 1st Workshop on "APEC Network of Pharmaceutical Regulatory Science - APEC Joint Research Project on Bridging Study". Taipei, Taiwan, May 2000
• Planning and Management of Clinical Trials for the Development of New Antihypertensive Medications. IX. Scientific Meeting of the Slovenian Hypertension Society, Smarjeske Toplice, September 2000
• Regulatory Strategies for NCE Products in the Emerging Markets. Annual Euromeeting DIA, Barcelona 2001
• Regulatory Challenges of Global Oncology Drug Development. 3rd Annual Conference on Clinical Trials for Anti-Cancer Drugs. San Francisco, CA, January 2002
• Regulatory Environment Outside of US and EU. New Trends in Regulatory Affairs on Medicinal Products for Human Use. Eudipharm, Brussels, Belgium, April 8, 2002
• Regulatory Affairs in the Emerging Markets. Organizer, a day and a half DIA tutorial. 2002 DIA 38th Annual Meeting, June 2002, Chicago
• Role of the Emerging Markets in the Design of the Global Regulatory Strategy. Session Chair. 2002 DIA 38th Annual Meeting, June 2002, Chicago
• Regulatory Harmonization in ASEAN - Implications for Global Drug Development. Session Chair. 2002 DIA 38th Annual Meeting, June 2002, Chicago
• Regulatory Implications of International Promotional Issues. At: DIA's Marketing of Pharmaceuticals: Defining the New Regulatory Paradigm. February 25, 2003, New York
• Regulatory Environment Outside of US and EU. New Trends in Regulatory Affairs on Medicinal Products for Human Use. Eudipharm, Brussels, Belgium, April 8, 2003
• Ethnic Factors in Drug Development. New Trends in Regulatory Affairs on Medicinal Products for Human Use. Eudipharm, Brussels, Belgium, April 8, 2003
• Japanese Regulatory Environment. New Trends in Regulatory Affairs on Medicinal Products for Human Use. Eudipharm, Brussels, Belgium, April 8, 2003
• Global Drug Development - Importance of Global Regulatory Strategy. Audioconference. Foreign-Exchange Translations, Inc. April 23, 2003
• Global Regulatory Affairs. Organizer, a DIA tutorial. 2003 DIA 39th Annual Meeting, June 15, 2003, San Antonio
• New Developments with the ASEAN Harmonization : Update of Local Experts. Session Chair. 2003 DIA 39th Annual Meeting, June 17, 2003, San Antonio
• Ethnic Factors in Drug Development. The Global Awareness: Asia Conference. RAPS, Universal City CA, June 23-24, 2003
• Ethnic Factors in Drug Development. IFPMA Training Meeting, Bangkok, Thailand, September 2003
• New Developments with the ASEAN Harmonization. 2003 RAPS Annual Meeting, October 22, 2003, Baltimore, MD
• Introduction to Conducting Clinical Trials in Asia Pacific. International Clinical Trials-Facilitating the Strategic Planning, Initiation and Management of Global Studies. Washington, D.C , November 10, 2003
• What Can Asia Learn From Europe? 3rd APEC Conference. Taipei, Taiwan, November 18, 2003
• Post-Marketing responsibilities of the Marketing Authorization Holder. At: Principles and Practices of EU Regulatory Affairs, RAPS, Arlington, VA, February 24, 2004
• Current Status and Issues with Global Acceptance of ICH. DIA EuroMeeting 2004, Prague, Czech Republic, March 12, 2004
• Regulatory Environment in Japan. Eudipharm, Brussels, April 16, 2004